Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? [interview] Journal Article


Author: Postow, M. A.
Article Title: Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? [interview]
Journal Title: Clinical Advances in Hematology & Oncology
Volume: 16
Issue: 5
ISSN: 1543-0790
Publisher: Millennium Medical Publishing, Inc  
Date Published: 2018-05-01
Start Page: 353
End Page: 355
Language: English
PROVIDER: scopus
PUBMED: 29851931
DOI/URL:
Notes: Note -- Export Date: 2 July 2018 -- Source: Scopus
MSK Authors
  1. Michael Andrew Postow
    195 Postow